The forearm fracture recovery in children evaluation study

ISRCTN ISRCTN13955395
DOI https://doi.org/10.1186/ISRCTN13955395
Secondary identifying numbers HTA 17/23/02; Sponsor PID: 13849
Submission date
12/10/2018
Registration date
12/10/2018
Last edited
01/08/2022
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Injury, Occupational Diseases, Poisoning
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English Summary

Background and study aims
Torus (buckle) fractures of the wrist are the most common fractures in children. They result from injury to growing bones and account for 500,000 UK emergency attendances annually. Torus fractures have a very low risk of complications and universally heal well. There is considerable variation in the treatment of torus fractures, from the use of a removable rigid splint, to plaster cast immobilisation, to more flexible splints or soft bandages. The key differences are the degree of immobilisation provided and the follow-up required. Non-removable rigid casts are no longer recommended for the treatment of these injuries. Removable splints immobilise the wrist and may provide the best pain relief. Soft bandaging restricts movement the least and may encourage early function, but concern remains about pain and the potential for complications, despite evidence to the contrary. The National Institute for Health and Care Excellence (NICE) concluded that bandaging was probably the best treatment approach due to the convenience, adequate pain control and the ability to promote early function, though asked whether any treatment is really necessary. NICE also recommended that no follow-up of these injuries is necessary because they are almost always complication free and they universally heal well. However, there is variable follow-up at different hospitals. The aim of this study is to assess the effectiveness of the optional use of soft bandage and immediate discharge, compared to rigid splint immobilisation.

Who can participate?
Children aged 4 to 15 with a torus fracture of the wrist

What does the study involve?
Each participant is randomly allocated to either a soft bandage and immediate discharge, or rigid splint immobilisation and follow-up as per current practice at the treating centre. Participants are asked to record their pain and complete questionnaires to assess their ability to use their arm and their quality of life. This information is collected by a smartphone/email link to an electronic questionnaire at various intervals over a 6-week period.

What are the possible benefits and risks of participating?
The results may show the best way to treat these injuries in the future. The treatments involved in this study are of no additional risk to the participant.

Where is the study run from?
John Radcliffe Hospital (UK)
The study will be recruiting from a minimum of 15 centres treating children’s fractures across the UK

When is the study starting and how long is it expected to run for?
July 2018 to August 2020

Who is funding the study?
NIHR Health Technology Assessment Programme (UK)

Who is the main contact?
Mrs Louise Spoors
FORCE@ndorms.ox.ac.uk

Study website

Contact information

Mrs Louise Spoors
Public

Kadoorie Centre
John Radcliffe Hospital
Oxford
OX39DU
United Kingdom

Phone +44 (0)1865 228929
Email FORCE@ndorms.ox.ac.uk
Mr Daniel Perry
Scientific

Kadoorie Centre
John Radcliffe Hospital
Oxford
OX39DU
United Kingdom

ORCiD logoORCID ID 0000-0001-8420-8252

Study information

Study designMulti-centre prospective randomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Study type Participant information sheet
Scientific titleA multi-centre prospective randomized equivalence trial of a soft bandage and immediate discharge versus current treatment with rigid immobilisation for torus fractures of the distal radius in children
Study acronymFORCE
Study hypothesisFORCE is an equivalence trial. The aim of this pragmatic RCT is to evaluate the clinical and cost-effectiveness of soft bandage immobilisation and immediate discharge, compared to rigid splint immobilisation and follow-up as per the protocol of the treating centre, for the treatment of torus fractures of the distal radius in children.
Ethics approval(s)Approved 16/11/2018, West Midlands – Solihull Research Ethics Committee (The Old Chapel, Royal Standard Place, Nottingham, NG1 6FS; Email: NRESCommittee.WestMidlands-Solihull@nhs.net), ref: 18/WM/0324
ConditionTorus (buckle) fractures of the distal radius in children
InterventionEach patient will be randomly allocated (1:1) with a randomisation sequence stratified by centre and age group (4-7 years and ≥8 years):
1. Soft bandage immobilisation and immediate discharge
2. Rigid splint immobilisation and follow-up as per the protocol of the treating centre

Participants are asked to record their pain and complete questionnaires to assess their ability to use their arm and their quality of life. This information will be collected via a smartphone/email link to an electronic questionnaire at various intervals over a 6 week period.
Intervention typeDevice
Pharmaceutical study type(s)
Phase
Drug / device / biological / vaccine name(s)
Primary outcome measurePain measured using the Wong-Baker FACES Pain Rating Scale at three days post randomisation
Secondary outcome measures1. Pain measured using the Wong-Baker FACES Pain Rating Scale at 1 day, 1, 3 and 6 weeks post randomisation
2. Use of regular analgesia assessed by questionnaire/survey via text at 1, 3 and 7 days post randomisation
3. Functional recovery measured using the Patient Report Outcomes Measurement System (PROMIS) Upper Extremity Limb Score for Children Computer Adaptive Test at 3 days, 1, 3 and 6 weeks post randomisation
4. Health-related quality of life measured using EQ-5DY at 3 days, 7 days, 3 and 6 weeks post randomisation
5. Number of days of school absence assessed by questionnaire/survey via text up to 3 and 6 weeks post randomisation
6. Complications, including the need for further hospital attendance, assessed by questionnaire/survey via text at 3 and 6 weeks post-randomisation
7. Resource use and comparative cost effectiveness assessed by questionnaire/survey via text at 3 and 6 weeks post randomisation
Overall study start date02/07/2018
Overall study end date31/08/2020

Eligibility

Participant type(s)Patient
Age groupChild
Lower age limit4 Years
Upper age limit15 Years
SexBoth
Target number of participants696
Total final enrolment965
Participant inclusion criteria1. Radiographic evidence of a torus fracture of the distal radius whereby there is a cortical deformation within the distal third of the radius but no break in the cortex. These may be associated with an ipsilateral fracture to the ulna (the ulna fracture may be buckle, greenstick or otherwise)
2. Aged 4 to 15 years old inclusive
3. Randomisation must occur at the site able to definitively treat the injury (i.e. a centre able to take the decision regarding the definitive treatment approach, which will typically be the emergency department)
Participant exclusion criteria1. The injury is more than 36 hours old
2. The treating clinician judges that there is a cortical disruption of the radius on radiographs (i.e. a greenstick fracture)
3. They have sustained an additional fracture at the time of the index fracture (with the exception of ipsilateral ulna fractures)
4. There is evidence that the patient and/or parent/guardian would be unable to adhere to trial procedures or complete follow-up, such as insufficient English language comprehension, developmental delay or a developmental abnormality or no access by parents to a telephone
Recruitment start date01/11/2018
Recruitment end date12/07/2020

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centres

John Radcliffe Hospital
Headington
Oxford
OX3 9DU
United Kingdom
Alder Hey Children’s Hospital
Eaton Road
Liverpool
L12 2AP
United Kingdom
Birmingham Children's Hospital
Steelhouse Ln
Birmingham
B4 6NH
United Kingdom
Bristol Royal Hospital for Children
Upper Maudlin Street
Bristol
BS2 8BJ
United Kingdom
University Hospital Coventry
Clifford Bridge Rd
Coventry
CV2 2DX
United Kingdom
Darlington Memorial Hospital
Hollyhurst Road
Darlington
DL3 6HX
United Kingdom
Royal Derby Hospital
Uttoxeter Road
Derby
DE22 3NE
United Kingdom
Horton General Hospital
Oxford Road
Banbury
OX16 9AL
United Kingdom
Ipswich Hospital
Heath Road
Ipswich
IP4 5PD
United Kingdom
Leicester Royal Infirmary
Infirmary Square
Leicester
LE1 5WW
United Kingdom
Nottingham University Hospital (Queen's Medical Centre)
Derby Rd
Nottingham
NG7 2UH
United Kingdom
Queens Hospital
Rom Valley Way
Romford
RM7 0AG
United Kingdom
Royal London Hospital
Whitechapel
E1 1BB
United Kingdom
Sheffield Children's Hospital
Western Bank
Sheffield
S10 2TH
United Kingdom
St George's Hospital
Blackshaw Rd
London
SW17 0QT
United Kingdom
Sunderland Royal Hospital
Kayll Road
Sunderland
SR4 7TP
United Kingdom
New Cross Hospital
Wednesfield Road
Wolverhampton
WV10 0QP
United Kingdom
University Hospital Southampton
University Hospital Southampton NHS Foundation Trust
Tremona Road
Southampton
SO16 6YD
United Kingdom
Royal Berkshire Hospital
Royal Berkshire NHS Foundation Trust
London Road
Reading
RG1 5AN
United Kingdom
Wexham Park Hospital
Frimley Health NHS Foundation Trust
Wexham Park
Slough
SL2 4HL
United Kingdom
Royal Devon & Exeter Hospitals
Royal Devon and Exeter NHS Foundation Trust
Barrack Rd
Exeter
EX2 5DW
United Kingdom
Evelina London Children's Hospital
Guy's and St Thomas' NHS Foundation Trust
Westminster Bridge Rd
Lambeth
London
SE1 7EH
United Kingdom

Sponsor information

University of Oxford
University/education

Joint Research Office
1st floor, Boundary Brook House
Churchill Drive
Headington
Oxford
OX3 7LQ
England
United Kingdom

Website http://www.ndorms.ox.ac.uk/clinical-trials/current-trials-and-studies/force
ROR logo "ROR" https://ror.org/052gg0110

Funders

Funder type

Government

Health Technology Assessment Programme
Government organisation / National government
Alternative name(s)
NIHR Health Technology Assessment Programme, HTA
Location
United Kingdom

Results and Publications

Intention to publish date01/12/2021
Individual participant data (IPD) Intention to shareYes
IPD sharing plan summaryAvailable on request
Publication and dissemination planThe protocol will be available on the NIHR website.

Dissemination of the results will be via traditional and novel methods:
1. Conference: Traditional conference dissemination will focus on presentations to include the key professional stakeholders (emergency medicine doctors, orthopaedic surgeons, emergency nurse practitioners and trainees in emergency medicine and orthopaedics)
2. Publications: Key outputs will be published in high-impact journals with publicity sought in other professional journals (e.g. Pulse, HSJ, Nursing Times). The trialists will ensure that plain English summaries are published alongside the full paper, along with links to other digital media on the trial website to explain the trial result in an accessible format – i.e. an explainer video and infographic. Given the frequency of the injury, this is also likely to be of interest to international press outlets
3. Policy Makers: The trialists will ensure the development of links with key organisations such as NICE, NHS Information Centre, NHS England and Quality Observatories to contribute to and capitalise on their networks. Most importantly the outputs will directly contribute to the NICE non-complex fracture guidelines, and will be directly relevant to the widely publicised Choosing Widely Campaign
4. Public Dissemination: To ensure a broad campaign the trialists will target a range of social media outlets (e.g. twitter and blogs such as MumsNet) with the explainer video and infographic. They will seek to engage the NHS Dissemination centre, and seek to publish ‘digital story’ as part of the ‘NIHR Signal’. Finally, they will produce a Wikipedia page for this injury (currently absent) and update this with the trial result

Added 27/03/2019:
The protocol will be available prior to the completion of recruitment. The Statistical Analysis Plan and Health Economics Analysis Plan will be prepared before the final data has been collected. It is planned that each of these will be published in open-access journals.

Added 30/12/2019:
The protocol (not peer reviewed) has been uploaded as an additional file.
IPD sharing planThe datasets generated during and analysed during the current study may be made available upon request. All data requests should be submitted to Daniel Perry (daniel.perry@ndorms.ox.ac.uk). Access to anonymised data may be granted following review.
Data will be freely available after the Monograph is published, and for 5 years thereafter, for anyone to look up and to use for whatever purpose. Individual patient data will be made available for IPD met analysis only, subject to agreement.
All data will be anonymised and any free text responses from participants removed to ensure this. All participants have consented to the study and there are no ethical or legal restrictions. Anonymised patient-level data will be shared in a format appropriate to the nature of the data-sharing project.

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Protocol file version V3.0 13/11/2019 30/12/2019 No No
Protocol article protocol 01/06/2020 05/08/2020 Yes No
Statistical Analysis Plan Statistical analysis plan 01/06/2020 05/08/2020 No No
Basic results 06/07/2022 06/07/2022 No No
Participant information sheet 06/07/2022 No Yes
Results article 02/07/2022 06/07/2022 Yes No
Other publications Does digital, multimedia information increase recruitment and retention in a children's wrist fracture treatment trial, and what do people think of it? A randomised controlled Study Within A Trial (SWAT) 13/07/2022 14/07/2022 Yes No
Results article 01/07/2022 01/08/2022 Yes No
HRA research summary 28/06/2023 No No

Additional files

ISRCTN13955395_FORCE_Protocol_V3.0_13Nov2019.pdf
uploaded 30/12/2019
ISRCTN13955395_BasicResults_06Jul2022.pdf

Editorial Notes

01/08/2022: Publication reference added.
14/07/2022: Publication reference added.
07/06/2022: The following changes have been made:
1. Publication reference added.
2. The participant information sheet link has been added.
3. A basic results file has been uploaded.
07/09/2021: The intention to publish date was changed from 14/01/2021 to 01/12/2021.
18/08/2020: IPD sharing statement added.
05/08/2020: The following changes were made to the trial record:
1. The recruitment end date was changed from 20/07/2020 to 12/07/2020.
2. The total final enrolment was added.
3. Publication references added.
06/07/2020: The following changes were made to the trial record:
1. The recruitment end date was changed from 30/06/2020 to 20/07/2020.
2. The overall trial end date was changed from 14/01/2021 to 31/08/2020.
3. The intention to publish date was changed from 14/01/2022 to 14/01/2021.
30/12/2019: Protocol file uploaded.
10/12/2019: The following changes were made to the trial record:
1. The recruitment end date was changed from 31/12/2019 to 30/06/2020.
2. The overall end date was changed from 30/06/2020 to 14/01/2021.
3. The intention to publish date was changed from 01/08/2020 to 14/01/2022.
4. The trial participating centres "University Hospital Southampton, Royal Berkshire Hospital, Wexham Park Hospital, Royal Devon & Exeter Hospitals, Evelina London Children's Hospital" were added.
5. The plain English summary was updated to reflect these changes.
16/10/2019: Internal review.
01/04/2019: Ethics approval details added.
27/03/2019: Publication and dissemination plan and IPD sharing statement updated, trial participating centres added.